Pharma Reviews: Aurobindo eyes rapid growth in US market
Notwithstanding the regulatory challenges, Aurobindo Pharma Ltd is betting big on the US market, which accounts for nearly half of the firm's revenue.
Read more: Aurobindo eyes rapid growth in US market